Syndrome d'hypersensibilité médicamenteuse (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Syndrome d'hypersensibilité médicamenteuse" in French language version.

refsWebsite

Global rank French rank

17nih.gov

4^th place

12^th place

7doi.org

2^nd place

3^rd place

2wiley.com

222^nd place

129^th place

1medicalforum.ch

low place

6,070^th place

1jamanetwork.com

2,650^th place

689^th place

1minervamedica.it

low place

1escholarship.org

1,523^rd place

2,842^nd place

1john-libbey-eurotext.fr

low place

5,813^th place

1dermnetnz.org

7,563^rd place

low place

1occup-med.com

low place

1ima.org.il

low place

1hindawi.com

6,828^th place

2,093^rd place

1sciencedirect.com

149^th place

80^th place

1medscimonit.com

low place

dermnetnz.org

(en) « Tetracycline (doxycycline, minocycline) »

doi.org

dx.doi.org

(en) Bocquet H, Bagot M, Roujeau JC, « Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) », Semin Cutan Med Surg, vol. 15, n^o 4,‎ décembre 1996, p. 250–7 (PMID 9069593, DOI 10.1016/S1085-5629(96)80038-1)
(en) Walsh SA, Creamer D, « Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking », Clinical and Experimental Dermatology, vol. 36, n^o 1,‎ janvier 2011, p. 6–11 (PMID 21143513, DOI 10.1111/j.1365-2230.2010.03967.x)
(en) Kardaun SH, Sidoroff A, Valeyrie-Allanore L. et al., « Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? », Response Br J Dermatol, vol. 156, n^o 3,‎ 2007, p. 609–610 (PMID 17300272, DOI 10.1111/j.1365-2133.2006.07704.x)
(en) Shiohara T, Iijima M, Ikezawa Z, Hashimoto K., « The diagnosis of DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations », Response Br J Dermatol, vol. 156, n^o 5,‎ 2007, p. 1045–1092 (PMID 17381452, DOI 10.1111/j.1365-2133.2007.07807.x)
(en) Chen YC, Chiu HC, Chu CY, « Drug Reaction With Eosinophilia and Systemic Symptoms: A retrospective study of 60 cases », Arch Dermatol, vol. 146, n^o 12,‎ 2010, p. 1373–1379 (PMID 20713773, DOI 10.1001/archdermatol.2010.198, lire en ligne)
(en) Z Husain, BY Reddy et RA Schwartz, « DRESS syndrome: Part II. Management and therapeutics », J Am Acad Dermatol., vol. 68, n^o 5,‎ 2013, p. 709.e1-9; quiz 718-20. (PMID 23602183, DOI 10.1016/j.jaad.2013.01.032)
(en) M. Ganeva et al., « Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review », International Journal of Dermatology, vol. 47, n^o 8,‎ 2008, p. 853–860 (PMID 18717872, DOI 10.1111/j.1365-4632.2008.03637.x)

escholarship.org

(en) Pierre-Dominique Ghislain et Jean-Claude Roujeau, « Treatment of severe drug reactions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis and Hypersensitivity syndrome », Dermatology Online Journal, vol. 8, n^o 1,‎ 2002, p. 5-5 (lire en ligne)

hindawi.com

(en) Cheng CY, Su SC, Chen CH, Chen WL, Deng ST, Chung WH, « HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review » J Immunol Res, 2014;2014:565320

ima.org.il

(en) A Markel, « Allopurinol-induced DRESS syndrome », Israel Medical Association Journal, vol. 7, n^o 10,‎ octobre 2005, p. 656–660 (PMID 16259349, lire en ligne [PDF])

jamanetwork.com

archderm.jamanetwork.com

(en) Chen YC, Chiu HC, Chu CY, « Drug Reaction With Eosinophilia and Systemic Symptoms: A retrospective study of 60 cases », Arch Dermatol, vol. 146, n^o 12,‎ 2010, p. 1373–1379 (PMID 20713773, DOI 10.1001/archdermatol.2010.198, lire en ligne)

john-libbey-eurotext.fr

(en) JP Allam, T Paus, C Reichel et al., « DRESS syndrome associated with carbamazepine and phenytoin », European Journal of Dermatology, vol. 14, n^o 5,‎ septembre-octobre 2004, p. 339–342 (PMID 15358574, lire en ligne)

medicalforum.ch

Werner J. Pichler, Thomas Wendland, Oliver Hausmann, Benno Schnyder, Michael Fricker, Christiane Pichler et Arthur Helbling, « Syndrome DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Une allergie médicamenteuse grave souvent méconnue », Forum Med Suisse, vol. 11, n^o 48,‎ 2011, p. 879–884 (lire en ligne [PDF])

medscimonit.com

(en) Moling O, Tappeiner L, Piccin A et al. « Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir—a hypothesis » Med Sci Monit, 2012;18:CS57-62

minervamedica.it

(en) Borroni G, Torti S, Pezzini C et al. « Histopathologic spectrum of drug reaction with eosinophilia and systemic symptoms (DRESS): a diagnosis that needs clinico-pathological correlation » G Ital Dermatol Venereol, 2014;149:291-300

nih.gov

ncbi.nlm.nih.gov

(en) Saltzstein SL, Ackerman LV, « Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas », Cancer, vol. 12, n^o 1,‎ 1959, p. 164–82 (PMID 13618867, lire en ligne [PDF])
(en) F. Haruda, « Phenytoin hypersensitivity: 38 cases », Neurology, vol. 29, n^o 11,‎ novembre 1979, p. 1480-1485. (PMID 574201)
(en) Bocquet H, Bagot M, Roujeau JC, « Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) », Semin Cutan Med Surg, vol. 15, n^o 4,‎ décembre 1996, p. 250–7 (PMID 9069593, DOI 10.1016/S1085-5629(96)80038-1)
(en) Walsh SA, Creamer D, « Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking », Clinical and Experimental Dermatology, vol. 36, n^o 1,‎ janvier 2011, p. 6–11 (PMID 21143513, DOI 10.1111/j.1365-2230.2010.03967.x)
(en) Kardaun SH, Sidoroff A, Valeyrie-Allanore L. et al., « Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? », Response Br J Dermatol, vol. 156, n^o 3,‎ 2007, p. 609–610 (PMID 17300272, DOI 10.1111/j.1365-2133.2006.07704.x)
(en) Shiohara T, Iijima M, Ikezawa Z, Hashimoto K., « The diagnosis of DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations », Response Br J Dermatol, vol. 156, n^o 5,‎ 2007, p. 1045–1092 (PMID 17381452, DOI 10.1111/j.1365-2133.2007.07807.x)
(en) Chen YC, Chiu HC, Chu CY, « Drug Reaction With Eosinophilia and Systemic Symptoms: A retrospective study of 60 cases », Arch Dermatol, vol. 146, n^o 12,‎ 2010, p. 1373–1379 (PMID 20713773, DOI 10.1001/archdermatol.2010.198, lire en ligne)
(en) P Tennis et RS Stem, « Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study », Neurology, n^o 49,‎ 1997, p. 542-546 (PMID 9270593)
(en) JP Allam, T Paus, C Reichel et al., « DRESS syndrome associated with carbamazepine and phenytoin », European Journal of Dermatology, vol. 14, n^o 5,‎ septembre-octobre 2004, p. 339–342 (PMID 15358574, lire en ligne)
(en) Kosseifi SG, Guha B, Nassour DN, Chi DS, Krishnaswamy G., « The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations », J Occup Med Toxicol., vol. 6, n^o 1,‎ juin 2006, p. 9 (PMID 16756657, lire en ligne)
(en) A Markel, « Allopurinol-induced DRESS syndrome », Israel Medical Association Journal, vol. 7, n^o 10,‎ octobre 2005, p. 656–660 (PMID 16259349, lire en ligne [PDF])
(en) V Descamps, F Bouscarat, S Laglenne et al., « Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome », Br J Dermatol., n^o 137,‎ 1997, p. 605-608 (PMID 9390340)
(en) Y Suzuki, R Inagi, T Aono, K Yamanishi et T Shiohara, « Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome », Arch Dermatol., n^o 134,‎ 1998, p. 1108-1112 (PMID 9762023)
(en) V Descamps, A Valance, C Edlinger et al., « Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms », Arch Dermatol., n^o 137,‎ 2001, p. 301-304 (PMID 11255328)
V. Descamps, « Syndrome d'hypersensibilité médicamenteuse ou DRESS [Drug reaction with eosinophilia and systemic symptoms (DRESS)] », Rev Prat., vol. 62, n^o 10,‎ décembre 2012, p. 1347-1352 (PMID 23424909)
(en) Z Husain, BY Reddy et RA Schwartz, « DRESS syndrome: Part II. Management and therapeutics », J Am Acad Dermatol., vol. 68, n^o 5,‎ 2013, p. 709.e1-9; quiz 718-20. (PMID 23602183, DOI 10.1016/j.jaad.2013.01.032)
(en) M. Ganeva et al., « Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review », International Journal of Dermatology, vol. 47, n^o 8,‎ 2008, p. 853–860 (PMID 18717872, DOI 10.1111/j.1365-4632.2008.03637.x)

occup-med.com

(en) Kosseifi SG, Guha B, Nassour DN, Chi DS, Krishnaswamy G., « The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations », J Occup Med Toxicol., vol. 6, n^o 1,‎ juin 2006, p. 9 (PMID 16756657, lire en ligne)

sciencedirect.com

(en) Descamps V, Ben Saïd B, Sassolas B et al. « Management of drug reaction with eosinophilia and systemic symptoms (DRESS) » Ann Dermatol Venereol, 2010;137:703-8

wiley.com

onlinelibrary.wiley.com

(en) Saltzstein SL, Ackerman LV, « Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas », Cancer, vol. 12, n^o 1,‎ 1959, p. 164–82 (PMID 13618867, lire en ligne [PDF])
Peyrière H, Dereure O, Breton H et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, Br J Dermatol, 2006;155:422-428